Download PDF

Other users also viewed these articles

Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC) A. Figueiredo, M.A. Almeida, M.T. Almodovar, P. Alves, A. Araújo, D. Araújo, F. Barata, L. Barradas, A. Barroso, U. Brito, E. Camacho, D. Canário, T. Cardoso, A. Chaves, L. Costa, J. Cunha, J. Duarte, F. Estevinho, M. Felizardo, J.P. Fernandes, L. Ferreira, P. Fidalgo, C. Freitas, P. Garrido, N. Gil, D. Hasmucrai, E. Jesus, J.A. Lopes, J.E. de Macedo, A. Meleiro, R. Neveda, F. Nogueira, M. Pantorotto, B. Parente, A. Pego, M. Rocha, J. Roque, C. Santos, J. Saraiva, E. Silva, S. Silva, S. Simões, M. Soares, E. Teixeira, T. Timóteo, V. Hespanhol
10.1016/j.pulmoe.2019.06.001
The function of miR-637 in non-small cell lung cancer progression and prognosis Teng Jia, Qingguang Zhang, Haitao Xu, Hongjian Liu, Xiaojie Gu
10.1016/j.pulmoe.2021.05.005
The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer A. Sakin, S. Sahin, M.M. atci, N. Yasar, C. Geredeli, F. Aksaray, S. Cihan
10.1016/j.pulmoe.2019.11.007